Skill Checkup: A Man Who Had Autologous Hematopoietic Stem Cell Transplantation Developed Acute Graft-vs-Host Disease

James L. Harper, MD


February 10, 2022

The mean incidence of veno-occlusive disease in post-hematopoietic stem cell transplantation populations is estimated to be 13.7% overall, although prevalence reports have ranged widely, from 0 to 62%, in individual studies. Multiorgan dysfunction occurs in one quarter to one third of patients with veno-occlusive disease; this disease with associated multiorgan dysfunction may be associated with a mortality rate > 80% after hematopoietic stem cell transplantation.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.